Your browser doesn't support javascript.
loading
Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients.
Cirillo, Alessio; Zizzari, Ilaria Grazia; Botticelli, Andrea; Strigari, Lidia; Rahimi, Hassan; Scagnoli, Simone; Scirocchi, Fabio; Pernazza, Angelina; Pace, Angelica; Cerbelli, Bruna; d'Amati, Giulia; Marchetti, Paolo; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara.
Affiliation
  • Cirillo A; Division of Oncology, Department of Radiological, Oncological and Pathological Science, Policlinico Umberto I, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Zizzari IG; Laboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Botticelli A; Laboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Strigari L; Division of Oncology, Department of Radiological, Oncological and Pathological Science, Policlinico Umberto I, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Rahimi H; Medical Physics Unit, "Sant'Orsola-Malpighi" Hospital, 40138 Bologna, Italy.
  • Scagnoli S; Laboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Scirocchi F; Division of Oncology, Department of Radiological, Oncological and Pathological Science, Policlinico Umberto I, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Pernazza A; Laboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Pace A; Department of Radiology, Oncology and Pathology, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Cerbelli B; Laboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
  • d'Amati G; Department of Radiology, Oncology and Pathology, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Marchetti P; Department of Radiology, Oncology and Pathology, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Nuti M; Istituto Dermopatico dell'Immacolata (IDI-IRCCS), 00161 Rome, Italy.
  • Rughetti A; Laboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Napoletano C; Laboratory of Tumor Immunology and Cell Therapies, Department of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
Int J Mol Sci ; 24(8)2023 Apr 12.
Article in En | MEDLINE | ID: mdl-37108276

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Head and Neck Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2023 Document type: Article Affiliation country: Italy Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Head and Neck Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2023 Document type: Article Affiliation country: Italy Country of publication: Switzerland